M型与XL型探头在非酒精性脂肪性肝病中肝硬度测定的统一解读
该前瞻性研究纳入496例非酒精性脂肪性肝病患者,在肝活检前1周内分别用M型和XL型探头行振动控制瞬时弹性成像。M型与XL型探头分别有391例(78.8%)和433例(87.3%)获得可靠肝硬度测定(p<0.001),两种探头诊断性能相似;按体重指数选用合适探头时,各纤维化分期的肝硬度中位数几乎一致,且严重脂肪变不增加XL型探头的肝硬度或假阳性诊断率。
要点
- 按体重指数选用M型或XL型探头时,各纤维化分期的肝硬度中位数几乎一致。
- 高体重指数而非严重脂肪变会升高肝硬度测定值。
- 按合适体重指数使用探头时,同一肝硬度临界值无需因脂肪变进一步调整。
核心结论
- 高体重指数而非严重脂肪变会升高肝硬度测定值;按合适体重指数使用M型和XL型探头时,可采用同一肝硬度临界值而无需因脂肪变进一步调整。
研究设计与样本
- 前瞻性招募496例非酒精性脂肪性肝病患者,在肝活检前1周内分别用M型和XL型探头行振动控制瞬时弹性成像。
主要发现
- M型探头有391例(78.8%)、XL型探头有433例(87.3%)获得可靠肝硬度测定(10次成功采集且四分位距与中位数比值≤0.30),两者比较p<0.001。
- 两种探头受试者工作特征曲线下面积相似:F2-4为0.75-0.88,F4为0.83-0.91。
- 同一患者中XL型探头测得的肝硬度低于M型探头,平均差值为2.3 kPa。
- 体重指数≥30 kg/m2的患者无论使用哪种探头肝硬度均更高。
- 体重指数<30 kg/m2用M型探头、≥30 kg/m2用XL型探头时,各纤维化分期的肝硬度中位数几乎一致且诊断性能相似;严重脂肪变不增加XL型探头的肝硬度或假阳性诊断率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The latest model of vibration-controlled transient elastography (VCTE) automatically selects M or XL probe according to patients' body built. We aim to test the application of a unified interpretation of VCTE results with probes appropriate for the body mass index (BMI) and hypothesise that this approach is not affected by hepatic steatosis. DESIGN: We prospectively recruited 496 patients with non-alcoholic fatty liver disease who underwent VCTE by both M and XL probes within 1 week before liver biopsy. RESULTS: 391 (78.8%) and 433 (87.3%) patients had reliable liver stiffness measurement (LSM) (10 successful acquisitions and IQR:median ratio ≤0.30) by M and XL probes, respectively (p<0.001). The area under the receiver operating characteristic curves was similar between the two probes (0.75-0.88 for F2-4, 0.83-0.91 for F4). When used in the same patient, LSM by XL probe was lower than that by M probe (mean difference 2.3 kPa). In contrast, patients with BMI ≥30 kg/m2 had higher LSM regardless of the probe used. When M and XL probes were used in patients with BMI <30 and ≥30 kg/m2, respectively, they yielded nearly identical median LSM at each fibrosis stage and similar diagnostic performance. Severe steatosis did not increase LSM or the rate of false-positive diagnosis by XL probe. CONCLUSION: High BMI but not severe steatosis increases LSM. The same LSM cut-offs can be used without further adjustment for steatosis when M and XL probes are used according to the appropriate BMI.
引用
- Wong VW, Irles M, Wong GL, et al. Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease. Gut. 2019. PMID: 30658997. doi:10.1136/gutjnl-2018-317334
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。